Krystal Biotech to Present at Chardan’s 6th Annual Genetic Medicines Conference
29 September 2022 - 9:00PM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in
redosable gene therapy, announced today that the Company will
participate in the Chardan’s 6th Annual Genetic Medicines
Conference in New York from October 3-4.
Krish Krishnan, Chairman and Chief Executive Officer, will
participate in a fireside chat during the conference and host
investor meetings on October 4.
A webcast of the presentation will be available here beginning
at 9:00am ET on Tuesday, October 4 and will be posted on the
Investor section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene
therapy company leveraging its proprietary, redosable gene therapy
platform and in-house manufacturing capabilities to develop
life-changing medicines for patients with serious diseases,
including rare diseases in skin, lung, and other areas. For more
information please visit http://www.krystalbio.com, and follow
@KrystalBiotech on LinkedIn and Twitter.
CONTACT:
Investors and MediaMeg DodgeKrystal
Biotechmdodge@krystalbio.comSource: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024